Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma

医学 表阿霉素 尿路上皮癌 泌尿科 上尿路 膀胱 泌尿系统 输尿管肿瘤 癌 移行细胞癌 膀胱癌 内科学 化疗 癌症 环磷酰胺
作者
Jong Hoon Lee,Chung Un Lee,Jae Hoon Chung,Wan Song,Minyong Kang,Hwang Gyun Jeon,Byong Chang Jeong,Seong Il Seo,Seong Soo Jeon,Hyun Hwan Sung
出处
期刊:Cancer Research and Treatment [Korean Cancer Association]
卷期号:56 (3): 877-884 被引量:4
标识
DOI:10.4143/crt.2023.1219
摘要

PURPOSE: We aimed to assess the effectiveness of early single intravesical administration of epirubicin in preventing intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. MATERIALS AND METHODS: Patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy between November 2018 and May 2022 were retrospectively reviewed. Intravesical epirubicin was administered within 48 hours if no evidence of leakage was observed. Epirubicin (50 mg) in 50 mL normal saline solution was introduced into the bladder via a catheter and maintained for 60 minutes. The severity of adverse events was graded using the Clavien-Dindo classification. We compared intravesical recurrence rate between the two groups. Multivariate analyses were performed to identify the independent predictors of bladder recurrence following radical nephroureterectomy. RESULTS: Epirubicin (n=55) and control (n=116) groups were included in the analysis. No grade 1 or higher bladder symptoms have been reported. A statistically significant difference in the intravesical recurrence rate was observed between the two groups (11.8% at 1 year in the epirubicin group vs. 28.4% at 1 year in the control group; log-rank p=0.039). In multivariate analysis, epirubicin instillation (hazard ratio [HR], 0.43; 95% confidence interval [CI], 0.20 to 0.93; p=0.033) and adjuvant chemotherapy (HR, 0.29; 95% CI, 0.13 to 0.65; p=0.003) were independently predictive of a reduced incidence of bladder recurrence. CONCLUSION: This retrospective review revealed that a single immediate intravesical instillation of epirubicin is safe and can reduce the incidence of intravesical recurrence after radical nephroureterectomy. However, further prospective trials are required to confirm these findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.3的应助被小慈采纳,获得10
1秒前
2秒前
怪怪完成签到,获得积分10
3秒前
ou发布了新的文献求助10
3秒前
顺利的飞荷完成签到,获得积分0
3秒前
5秒前
miaotiao完成签到,获得积分10
5秒前
5秒前
6秒前
MZ发布了新的文献求助10
8秒前
万能图书馆的应助被邬梦寒采纳,获得20
11秒前
11秒前
vivre223完成签到 ,获得积分10
11秒前
余香的应助被侯侯采纳,获得10
11秒前
12秒前
13秒前
Maestro_S的应助被MZ采纳,获得10
14秒前
挂机了完成签到,获得积分10
14秒前
夏姬宁静完成签到,获得积分10
14秒前
细胞核完成签到,获得积分10
15秒前
su完成签到,获得积分10
15秒前
啊啊完成签到,获得积分10
15秒前
15秒前
进取拼搏完成签到,获得积分10
15秒前
传奇3的应助被爱听歌的妙柏采纳,获得10
15秒前
16秒前
18秒前
18秒前
tianyiweilan发布了新的文献求助10
18秒前
18秒前
19秒前
19秒前
lllcy发布了新的文献求助10
19秒前
wz完成签到,获得积分10
20秒前
欣欣发布了新的文献求助10
20秒前
QDU的应助被行者采纳,获得20
20秒前
忧郁的流沙完成签到,获得积分10
20秒前
21秒前
柳叶刀发布了新的文献求助10
21秒前
2mo完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193729
求助须知:如何正确求助?哪些是违规求助? 9579876
关于积分的说明 21868333
捐赠科研通 7793519
什么是DOI,文献DOI怎么找? 3437414
关于科研通互助平台的介绍 2560856
邀请新用户注册赠送积分活动 2484216